Trial Profile
Analysis of therapeutic response onset time in thyroid cancer patients treated by lenvatinib
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs Lenvatinib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 30 Oct 2015 New trial record